Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
RECOMBINANT SUBUNIT VACCINE AGAINST RSV AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/093554
Kind Code:
A1
Abstract:
The present invention relates to the field of biomedicine, in particular to a recombinant subunit vaccine against respiratory syncytial virus (RSV) and a use thereof, and more in particular to a recombinant fusion protein containing the Head only (RHF) domain of an RSV envelope fusion protein F and a multimerization domain such as an immunoglobulin Fc fragment, an expression construct containing the recombinant fusion protein, a preparation method for the recombinant fusion protein, and an immunogenic composition containing the recombinant fusion protein, such as a vaccine.

Inventors:
JIANG DUNQUAN (CN)
LIU YONGJIANG (CN)
ZHANG SHIBIN (CN)
HUANG PEIXIN (CN)
CHEN JUNNA (CN)
YIN YAJIE (CN)
LIU YUYING (CN)
ZHANG HUAN (CN)
JIANG PING (CN)
YIN FEI (CN)
JIANG XULIN (CN)
ZHANG YAO (CN)
SHEN ERCUI (CN)
YANG XIUFEN (CN)
WANG YAN (CN)
GAO JUN (CN)
Application Number:
PCT/CN2023/119638
Publication Date:
May 10, 2024
Filing Date:
September 19, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BEIJING HEALTH GUARD BIOTECHNOLOGY INC (CN)
International Classes:
C07K19/00; A61K39/155; A61P11/00; C07K14/135
Foreign References:
US20190330277A12019-10-31
CN104334188A2015-02-04
CN107847580A2018-03-27
CN108738312A2018-11-02
Attorney, Agent or Firm:
NTD UNIVATION INTELLECTUAL PROPERTY AGENCY LTD. (CN)
Download PDF: